Jim Simons's position in Haemonetics is currently worth $11.7 Million. That's 0.02% of their equity portfolio (847th largest holding). The first Haemonetics trade was made in Q2 2013. Since then Jim Simons bought shares 23 more times and sold shares on eighteen occasions. The investor's estimated purchase price is $12.3 Million, resulting in a loss of 5.3%.